Back to Search
TAHSEEN AL-SALEEM, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1962474056Individual
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
MD050150L(PA)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
MD050150L(PA)
Research & Publications (20)
Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression?
PMID 16271962·Cancer Genet Cytogenet·2005
5-case
Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.
PMID 15542584·Blood·2005
6-review
The genetics of renal oncocytosis: a possible model for neoplastic progression.
PMID 15193438·Cancer Genet Cytogenet·2004
5-case
Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma.
PMID 19567676·Cancer Res·2009
7-preclinical
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Review: lymphomatoid granulomatosis: challenges in diagnosis and treatment.
PMID 19274044·Clin Adv Hematol Oncol·2009
6-review
The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.
PMID 19234517·Oncogene·2009
7-preclinical
Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature.
PMID 18794461·Arch Dermatol·2008
5-case
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
PMID 18455330·Int J Radiat Oncol Biol Phys·2008
3-trial
Pathologic concordance of sporadic synchronous bilateral renal masses.
PMID 18336882·Urology·2008
8-other
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
PMID 18281473·Cancer Res·2008
8-other
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
PMID 17575222·Clin Cancer Res·2007
3-trial
Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.
PMID 17420979·Cancer·2007
5-case
The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer.
PMID 17241749·Int J Radiat Oncol Biol Phys·2007
8-other
Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature.
PMID 17065004·Leuk Lymphoma·2006
5-case
Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
PMID 16707423·Cancer Res·2006
8-other
Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
PMID 16043218·Leuk Res·2006
5-case
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610.
PMID 16007688·Cancer·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 333 COTTMAN AVE, FOX CHASE CANCER CENTER
PHILADELPHIA, PA 19111 - Phone
- (214) 728-6900
Quick Facts
- NPI
- 1962474056
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile